These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17921968)

  • 21. The prognostic role of the pathological T2 subclassification for prostate cancer in the 2002 Tumour-Nodes-Metastasis staging system.
    van Oort IM; Witjes JA; Kok DE; Kiemeney LA; Hulsbergen-Van De Kaa CA
    BJU Int; 2008 Aug; 102(4):438-41. PubMed ID: 18336608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Re: PI-RADS version 2: what you need to know.
    Scialpi M; Martorana E; Scialpi P; D'Andrea A
    Clin Radiol; 2016 Sep; 71(9):934-5. PubMed ID: 27216080
    [No Abstract]   [Full Text] [Related]  

  • 23. A cancer staging perspective: the value of anatomical staging.
    Greene FL
    J Surg Oncol; 2007 Jan; 95(1):6-7. PubMed ID: 17192884
    [No Abstract]   [Full Text] [Related]  

  • 24. Re: PI-RADS version 2: what you need to know. A reply.
    Barrett T
    Clin Radiol; 2016 Sep; 71(9):935. PubMed ID: 27177852
    [No Abstract]   [Full Text] [Related]  

  • 25. Re: Axel Heidenreich, Gunnar Aus, Michel Bolla, et al. EAU guidelines on prostate cancer. Eur Urol 2008;53:68-80.
    Kirollos M
    Eur Urol; 2008 Sep; 54(3):693-5; author reply 695-7. PubMed ID: 18367315
    [No Abstract]   [Full Text] [Related]  

  • 26. Proton spectroscopic and dynamic contrast-enhanced magnetic resonance: a modern approach in prostate cancer imaging.
    Sciarra A; Salciccia S; Panebianco V
    Eur Urol; 2008 Sep; 54(3):485-8. PubMed ID: 18439748
    [No Abstract]   [Full Text] [Related]  

  • 27. Cancer staging.
    McKenna RJ
    Semin Surg Oncol; 1992; 8(2):55-6. PubMed ID: 1615263
    [No Abstract]   [Full Text] [Related]  

  • 28. Editorial comment on: Insignificant prostate cancer and active surveillance: from definition to clinical implications.
    Aus G
    Eur Urol; 2009 Jun; 55(6):1331. PubMed ID: 19286303
    [No Abstract]   [Full Text] [Related]  

  • 29. The evolving TNM cancer staging system: an essential component of cancer care.
    Brierley J;
    CMAJ; 2006 Jan; 174(2):155-6. PubMed ID: 16415456
    [No Abstract]   [Full Text] [Related]  

  • 30. Can we accurately identify men with low risk prostate cancer?
    Neal DE
    J Urol; 2008 Oct; 180(4):1217-8. PubMed ID: 18707718
    [No Abstract]   [Full Text] [Related]  

  • 31. Editorial comment on: Insignificant prostate cancer and active surveillance: from definition to clinical implications.
    Albertson PC
    Eur Urol; 2009 Jun; 55(6):1331-2. PubMed ID: 19286304
    [No Abstract]   [Full Text] [Related]  

  • 32. Magnetic resonance spectroscopic imaging: current status in the management of prostate cancer.
    Nayyar R; Kumar R; Kumar V; Jagannathan NR; Gupta NP; Hemal AK
    BJU Int; 2009 Jun; 103(12):1614-20. PubMed ID: 19338548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostatic transitional cell carcinoma: pathologic features and clinical management.
    Shen SS; Lerner SP
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1155-62. PubMed ID: 18028024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advancements in magnetic resonance imaging of the prostate.
    Macura KJ
    Top Magn Reson Imaging; 2008 Dec; 19(6):259-60. PubMed ID: 19512847
    [No Abstract]   [Full Text] [Related]  

  • 35. Early detection the key to prostate cancer.
    Kirby R
    Practitioner; 2009 Feb; 253(1715):17-8, 21-2. PubMed ID: 19326658
    [No Abstract]   [Full Text] [Related]  

  • 36. [Biomarkers for prostate cancer in predicting diagnosis, staging and prognosis].
    Ohori M
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):6-10. PubMed ID: 19151558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reacting to changes in staging designations in the 7th edition of the AJCC staging manual.
    Boffa DJ; Greene FL
    Ann Surg Oncol; 2011 Jan; 18(1):1-3. PubMed ID: 21063790
    [No Abstract]   [Full Text] [Related]  

  • 38. [Current methods of radical treatment for localized prostate cancer].
    Kaprin AD; Khmelevskiĭ EV; Fadeev AV
    Vopr Onkol; 2008; 54(1):108-12. PubMed ID: 18416071
    [No Abstract]   [Full Text] [Related]  

  • 39. [(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer.
    Tuncel M; Souvatzoglou M; Herrmann K; Stollfuss J; Schuster T; Weirich G; Wester HJ; Schwaiger M; Krause BJ
    Nucl Med Biol; 2008 Aug; 35(6):689-95. PubMed ID: 18678354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current status of MRI for the diagnosis, staging and prognosis of prostate cancer: implications for focal therapy and active surveillance.
    Villers A; Lemaitre L; Haffner J; Puech P
    Curr Opin Urol; 2009 May; 19(3):274-82. PubMed ID: 19325494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.